ONTARIO MEDICAL POLITICS
Blog about the Politics of Medicine
Monday, August 15, 2011
ROCHE: ACTEMRA: $24,000/year.
ROCHE RoACTEMRA approved in UK for Juvenile RA.
ROCHE multi-country ACTEMRA trial on Ankylosing Spondylitis not yet published.
DRUG cost of 400mg MONTHLY sub.cut infusion $1700. (4-8mg/kg).
40 years treatment = $1-mill.
Newer Posts
Older Posts
Home
Subscribe to:
Posts (Atom)